Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064443971> ?p ?o ?g. }
- W2064443971 endingPage "241" @default.
- W2064443971 startingPage "235" @default.
- W2064443971 abstract "Introduction Treatment with oxaloacetate after traumatic brain injury has been shown to decrease blood glutamate levels and protect against the neurotoxic effects of glutamate on the brain. A number of potential mechanisms have been suggested to explain oxaloacetate-induced neuroprotection. We hypothesize that the primary mechanism by which intravenous oxaloacetate provides neuroprotection is by activation of the blood glutamate-scavenging enzyme glutamate-oxaloacetate transaminase, increasing thereby the driving force for the efflux of excess glutamate from brain interstitial fluids into blood. If so, coadministration of maleate, a glutamate-oxaloacetate transaminase-blocker is expected to prevent the neuroprotective effects of oxaloacetate. Materials and Methods A neurological severity score (NSS) was measured 1 hour after closed head injury (CHI) in rats. Then, rats received 30 μL/min/100 g infusion of saline, or 1 mmol/100 g solution of oxaloacetate, maleate, or a mixture of oxaloacetate and maleate. NSS was reassessed at 24 and 48 hour after CHI. Blood glutamate and glucose levels were measured at 0, 60, 90, and 120 minutes. Results NSS improved significantly at 24 hour (P<0.001) and 48 hour (P<0.001) only in the rats treated with oxaloacetate. Blood glutamate decreased significantly in the oxaloacetate-treated group at 90 minute (at the conclusion of oxaloacetate administration) (P<0.00001), but not in the control, maleate or oxaloacetate+maleate groups. A strong correlation r2=0.86 was found to exist between the percent decrease in blood glutamate levels and percent improvement in NSS. Discussion The results of this study demonstrate that the primary mechanism by which oxaloacetate provides neuroprotective activity after CHI is related to its blood glutamate scavenging activity. Management of blood glutamate concentration may have important implications in the treatment of acute brain conditions, including CHI and stroke." @default.
- W2064443971 created "2016-06-24" @default.
- W2064443971 creator A5002684795 @default.
- W2064443971 creator A5017249320 @default.
- W2064443971 creator A5030281337 @default.
- W2064443971 creator A5047371057 @default.
- W2064443971 creator A5052353952 @default.
- W2064443971 creator A5070707226 @default.
- W2064443971 creator A5074533002 @default.
- W2064443971 creator A5076227268 @default.
- W2064443971 creator A5078495988 @default.
- W2064443971 creator A5089975936 @default.
- W2064443971 date "2009-07-01" @default.
- W2064443971 modified "2023-09-25" @default.
- W2064443971 title "The Neuroprotective Effects of Oxaloacetate in Closed Head Injury in Rats is Mediated by its Blood Glutamate Scavenging Activity" @default.
- W2064443971 cites W1543554996 @default.
- W2064443971 cites W1820824149 @default.
- W2064443971 cites W1933759996 @default.
- W2064443971 cites W1964535311 @default.
- W2064443971 cites W1978710583 @default.
- W2064443971 cites W1984338769 @default.
- W2064443971 cites W1988408232 @default.
- W2064443971 cites W1992177920 @default.
- W2064443971 cites W1992228316 @default.
- W2064443971 cites W1993331896 @default.
- W2064443971 cites W1995776925 @default.
- W2064443971 cites W2003068392 @default.
- W2064443971 cites W2026022416 @default.
- W2064443971 cites W2027397876 @default.
- W2064443971 cites W2029379167 @default.
- W2064443971 cites W2040808375 @default.
- W2064443971 cites W2042200838 @default.
- W2064443971 cites W2048841941 @default.
- W2064443971 cites W2063541383 @default.
- W2064443971 cites W2073595496 @default.
- W2064443971 cites W2078071611 @default.
- W2064443971 cites W2078517229 @default.
- W2064443971 cites W2087916050 @default.
- W2064443971 cites W2092658609 @default.
- W2064443971 cites W2106731245 @default.
- W2064443971 cites W2110634350 @default.
- W2064443971 cites W2130190854 @default.
- W2064443971 cites W2137491003 @default.
- W2064443971 cites W2164254780 @default.
- W2064443971 cites W4210979710 @default.
- W2064443971 cites W4246522549 @default.
- W2064443971 cites W75328843 @default.
- W2064443971 doi "https://doi.org/10.1097/ana.0b013e3181a2bf0b" @default.
- W2064443971 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19543002" @default.
- W2064443971 hasPublicationYear "2009" @default.
- W2064443971 type Work @default.
- W2064443971 sameAs 2064443971 @default.
- W2064443971 citedByCount "54" @default.
- W2064443971 countsByYear W20644439712012 @default.
- W2064443971 countsByYear W20644439712013 @default.
- W2064443971 countsByYear W20644439712014 @default.
- W2064443971 countsByYear W20644439712015 @default.
- W2064443971 countsByYear W20644439712016 @default.
- W2064443971 countsByYear W20644439712017 @default.
- W2064443971 countsByYear W20644439712018 @default.
- W2064443971 countsByYear W20644439712019 @default.
- W2064443971 countsByYear W20644439712020 @default.
- W2064443971 countsByYear W20644439712022 @default.
- W2064443971 crossrefType "journal-article" @default.
- W2064443971 hasAuthorship W2064443971A5002684795 @default.
- W2064443971 hasAuthorship W2064443971A5017249320 @default.
- W2064443971 hasAuthorship W2064443971A5030281337 @default.
- W2064443971 hasAuthorship W2064443971A5047371057 @default.
- W2064443971 hasAuthorship W2064443971A5052353952 @default.
- W2064443971 hasAuthorship W2064443971A5070707226 @default.
- W2064443971 hasAuthorship W2064443971A5074533002 @default.
- W2064443971 hasAuthorship W2064443971A5076227268 @default.
- W2064443971 hasAuthorship W2064443971A5078495988 @default.
- W2064443971 hasAuthorship W2064443971A5089975936 @default.
- W2064443971 hasConcept C111133373 @default.
- W2064443971 hasConcept C126322002 @default.
- W2064443971 hasConcept C170493617 @default.
- W2064443971 hasConcept C181199279 @default.
- W2064443971 hasConcept C185592680 @default.
- W2064443971 hasConcept C25498285 @default.
- W2064443971 hasConcept C2776877979 @default.
- W2064443971 hasConcept C55493867 @default.
- W2064443971 hasConcept C61174792 @default.
- W2064443971 hasConcept C71924100 @default.
- W2064443971 hasConcept C98274493 @default.
- W2064443971 hasConceptScore W2064443971C111133373 @default.
- W2064443971 hasConceptScore W2064443971C126322002 @default.
- W2064443971 hasConceptScore W2064443971C170493617 @default.
- W2064443971 hasConceptScore W2064443971C181199279 @default.
- W2064443971 hasConceptScore W2064443971C185592680 @default.
- W2064443971 hasConceptScore W2064443971C25498285 @default.
- W2064443971 hasConceptScore W2064443971C2776877979 @default.
- W2064443971 hasConceptScore W2064443971C55493867 @default.
- W2064443971 hasConceptScore W2064443971C61174792 @default.
- W2064443971 hasConceptScore W2064443971C71924100 @default.
- W2064443971 hasConceptScore W2064443971C98274493 @default.
- W2064443971 hasIssue "3" @default.
- W2064443971 hasLocation W20644439711 @default.